Mast cell and eosinophil activation during early phase of grass pollen-induced ocular allergic reaction

Allergy and Asthma Proceedings

Volumn 32, Issue 1, 2011, Pages 43-48

  Jedrzejczak Czechowicz, Monika ^a   Lewandowska Polak, Anna ^a   Jarzebska, Marzanna ^a   Kowalski, Marek L ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EOSINOPHIL CATIONIC PROTEIN; TRYPTASE;

ADULT; ALLERGIC REACTION; ARTICLE; CELL ACTIVATION; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; EOSINOPHIL; EYE ALLERGY; FEMALE; GRASS POLLEN; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; LACRIMAL FLUID; MALE; MAST CELL; PRICK TEST; RHINOCONJUNCTIVITIS;

ADOLESCENT; ADULT; ALLERGENS; CHILD; CONJUNCTIVITIS, ALLERGIC; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; MALE; MAST CELLS; POACEAE; POLLEN; RHINITIS, ALLERGIC, SEASONAL; TEARS; TRYPTASES; YOUNG ADULT;

EID: 79251603172     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2011.32.3402     Document Type: Article

References (49)

1. Leonardi A, Motterle L, and Bortolotti M. Allergy and the eye. Clin Exp Immunol 153(suppl 1):17-21, 2008.
2. Berdy GJ, and Berdy SS. Ocular allergic disorders: Disease entities and differential diagnoses. Curr Allergy Asthma Rep 9:297-303, 2009.
3. Bogacka E, Górski P, Groblewska A, et al. Polskiego Towarzystwa Alergologicznego; Polish Society of Allergology; Polskiego Towarzystwa Okulistycznego; Polish Society of Ophthalmology. Polish agreement in ocular allergy diagnostics and treatment [in Polish]. Klin Oczna 110:219-226, 2008.
4. Hodges MG, and Keane-Myers AM. Classification of ocular allergy. Curr Opin Allergy Clin Immunol 7:424-428, 2007.
5. Granet D. Allergic rhinoconjunctivitis and differential diagnosis of the red eye. Allergy Asthma Proc 29:565-574, 2008.
6. Naclerio RM, Pinto J, deTineo M, and Baroody FM. Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc 29:24-28, 2008.
7. Leonardi A. In-vivo diagnostic measurements of ocular inflammation. Curr Opin Allergy Immunol 5:464-472, 2005. (Pubitemid 41345318)
8. Bielory L. Allergic and immunologic disorders of the eye. J Allergy Clin Immunol 106:1019-1032, 2000.
9. Leonardi A, De Dominicis C, and Motterle L. Immunopathogenesis of ocular allergy: A schematic approach to different clinical entities. Curr Opin Allergy Clin Immunol 7:429-435, 2007. (Pubitemid 47415288)
10. Broide DH. The pathophysiology of allergic rhinoconjunctivitis. Allergy Asthma Proc 28:398-403, 2007.
11. Jutel M, Watanabe T, Akdis M, et al. Immune regulation by histamine. Curr Opin Immunol 14:735-740, 2002.
12. Leonardi A, Curnow SJ, Zhan H, et al. Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures. Clin Exp Allergy 36:777-784, 2006. (Pubitemid 43972973)
13. Graziano FM, Stahl JL, Cook EB, and Barney NP. Conjunctival mast cells in ocular allergic disease. Allergy Asthma Proc 22:121-126, 2001.
14. Choi SH, and Bielory L. Late-phase reaction in ocular allergy. Curr Opin Allergy Clin Immunol 8:438-444, 2008.
15. Ono SJ, and Abelson MB. Allergic conjunctivitis: Update on pathophysiology and prospects for future treatment. J Allergy Clin Immunol 115:118-122, 2005.
16. Tomasini M, Magrini L, and De Petrillo G. Serum levels of eosinophilic cationic protein in allergic diseases and natura alergen exposure. J Allergy Clin Immunol 97:1350-1355, 1996. (Pubitemid 26192286)
17. Cook EB. Tear cytokines in acute and chronic ocular allergic inflammation. Curr Opin Allergy Clin Immunol 4:441-445, 2004.
18. McGill J. Conjunctival cytokines in ocular allergy. Clin Exp Allergy 30:1355-1357, 2000.
19. Bacon AS, Ahluwalia P, Irani AM, et al. Tear and conjunctival changes during the allergen-induced early and late-phase responses. J Allergy Clin Immunol 106:948-954, 2000.
20. Bonini S, Bonini S, Berruto A, et al. Conjunctival provocation test as a model for the study of allergy and inflammation in humans. Int Arch Allergy Appl Immunol 88:144-148, 1989. (Pubitemid 19100621)
21. Abelson MB, Chambers WA, Smith LM, et al. Conjunctival allergen challenge. A clinical approach to studying allergic conjunctivitis. Arch Ophthalmol 108:84-88, 1990.
22. Radcliffe MJ, Lewith GT, Prescott P, et al. Do skin prick and conjunctival provocation tests predict symptom severity in seasonal allergic rhinoconjunctivitis? Clin Exp Allergy 36:1488-1493, 2006.
23. Bertel F, Mortemousque B, Sicard H, et al. Conjunctival provocation test with Dermatophagoides pteronyssinus in the diagnosis of allergic conjunctivitis from house mites. J Fr Ophtalmol 24:581-589, 2001.
24. Mortemousque B, Fauquert JL, Chiambaretta F, et al. Conjunctival provocation test: Recommendations [in French]. J Fr Ophtalmol 29:837-846, 2006.
25. Wang HF, Fukuda M, and Shimomura Y. Diagnosis of dry eye. Semin Ophthalmol 20:53-62, 2005.
26. Onguchi T, Dogru M, Okada N, et al. The impact of the onset time of atopic keratoconjunctivitis on the tear function and ocular surface findings. Am J Ophthalmol 141:569-571, 2006. (Pubitemid 43265970)
27. Roberts G, Hurley C, Turcanu V, et al. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J Allergy Clin Immunol 117:263-268, 2006. (Pubitemid 43190138)
28. Klimek L, Mewes T, Wolf H, et al. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity. Otolaryngol Head Neck Surg 133:538-543, 2005. (Pubitemid 41431842)
29. Corrigan CJ, Kettner J, Doemer C, et al. Efficacy and safety of preseasonal-specific immunotherapy with an aluminum-adsorbed six-grass pollen allergoid Allergy 60:801-807, 2005.
30. Lizaso MT, Tabar AI, García BE, et al. Double-blind, placebo-controlled Alternaria alternata immunotherapy: In vivo and in vitro parameters. Pediatr Allergy Immunol 19:76-81, 2008.
31. Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 62:943-948, 2007.
32. Senti G, Johansen P, Haug S, et al. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: A phase I/IIa clinical trial. Clin Exp Allergy 39:562-570, 2009.
33. Riechelmann H, Epple B, and Gropper G. Comparison of conjunctival and nasal provocation test in allergic rhinitis to mouse dust mite. Int Arch Allergy Immunol 103:51-59, 2003.
34. Proud D, Sweet J, and Stein P. Inflammatory mediator release on conjunctival provocation of allergic subjects with allergen. J Allergy Clin Immunol 85:896-905, 1990. (Pubitemid 20173127)
35. Matsuda A, Okayama Y, Terai N, et al. The role of interleukin-33 in chronic allergic conjunctivitis. Invest Ophthalmol Vis Sci 50:4646-4652, 2009.
36. Kowalski ML, Grzegorczyk J, Sliwinska-Kowalska M, et al. Neutrophil chemotactic activity (NCA) in nasal secretions from atopic and nonatopic subjects. Effect of antigen challenge. Allergy 48:409-414, 1993.
37. Leonardi AA, Smith LM, Fregona IA, et al. Tear histamine and histaminase during the early (EPR) and late (LPR) phases of the allergic reaction and the effects of lodoxamide. Eur J Ophthalmol 6:106-112, 1996.
38. Muromoto K, Shoji J, Inada N, et al. Tear eosinophil cationic protein measurement in patients with seasonal allergic conjunctivitis. Nippon Ganka Gakkai Zasshi 110:13-18, 2006.
39. Meijer F, Tak C, van Haeringen NJ, et al. Interaction between nitric oxide and prostaglandin synthesis in the acute phase of allergic conjunctivitis. Prostaglandins 52:431-446, 1996.
40. Wang D, Clement P, Smitz J, et al. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure. Int Arch Allergy Immunol 106:278-285, 1995.
41. Kowalski ML, Grzegorczyk J, Wojciechowska, et al. Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin Exp Allergy 26:807-814, 1996.
42. Montan PG, van Hage-Hamsten M, and Zetterstrom O. Sustained eosinophil cationic protein release into tears after a single high-dose conjunctival allergen challenge. Clin Exp Allergy 26:1125-1130, 1996.
43. Montan PG, and van Hage-Hamsten M. Eosinophil cationic protein in tears in allergic conjunctivitis. Br J Ophthalmol 80:556-560, 1996. (Pubitemid 26187093)
44. Fierro IM, and Serhan CN. Mechanisms in anti-inflammation and resolution: The role of lipoxins and aspirin-triggered lipoxins. Braz J Med Biol Res 34:555-566, 2001.
45. Profita M, Vignola AM, Sala A, et al. Interleukin-4 enhances 15-lipoxygenase activity and incorporation of 15(S)-HETE into cellular phospholipids in cultured pulmonary epithelial cells. Am J Respir Cell Mol Biol 20:61-68, 1999.
46. Kumlin M, Hamberg M, Granstrom E, et al. 15(S)-Hydroxyeicosatetraenoic acid is the major arachidonic acid metabolite in human bronchi: Association with airway epithelium. Arch Biochem Biophys 282:254-262, 1990.
47. Krawiec ME, Westcott JY, Chu HW, et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. Am J Respir Crit Care Med 163:1338-1343, 2001. (Pubitemid 32506596)
48. Kowalski ML, Ptasinska A, Jedrzejczak M, et al. Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPITest). Allergy 60:1139-1145, 2005.
49. Jedrzejczak-Czechowicz M, Lewandowska-Polak A, Bienkiewicz B, and Kowalski ML. Involvement of 15-lipoxygenase and prostaglandin EP receptors in aspirin (ASA)-triggered 15-HETE generation in ASA-sensitive asthmatics. Clin Exp Allergy 38:1108-1116, 2008.